Results     31-May-23
Announcements
Astrazeneca Pharma India standalone net profit declines 38.28% in the March 2023 quarter
Sales rise 22.74% to Rs 284.70 crore
Net profit of Astrazeneca Pharma India declined 38.28% to Rs 17.27 crore in the quarter ended March 2023 as against Rs 27.98 crore during the previous quarter ended March 2022. Sales rose 22.74% to Rs 284.70 crore in the quarter ended March 2023 as against Rs 231.96 crore during the previous quarter ended March 2022.

For the full year,net profit rose 61.21% to Rs 99.29 crore in the year ended March 2023 as against Rs 61.59 crore during the previous year ended March 2022. Sales rose 24.50% to Rs 1002.97 crore in the year ended March 2023 as against Rs 805.60 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales284.70231.96 23 1002.97805.60 25
OPM %21.0216.36 -15.8610.70 -
PBDT67.7641.43 64 184.5999.98 85
PBT63.5137.02 72 174.3383.03 110
NP17.2727.98 -38 99.2961.59 61

Previous News
  Astrazeneca Pharma India standalone net profit rises 128.60% in the March 2024 quarter
 ( Results - Announcements 28-May-24   07:37 )
  AstraZeneca Pharma India fixes record date for dividend
 ( Market Beat - Reports 03-Jul-23   18:19 )
  Volumes spurt at Godrej Industries Ltd counter
 ( Hot Pursuit - 27-May-22   14:30 )
  Volumes spurt at AIA Engineering Ltd counter
 ( Hot Pursuit - 12-Nov-20   11:00 )
  AstraZeneca Pharma India and Mankind Pharma ink distribution agreement
 ( Corporate News - 11-Mar-24   15:39 )
  Astrazeneca Pharma India standalone net profit rises 3322.50% in the September 2017 quarter
 ( Results - Announcements 07-Nov-17   16:18 )
  Astrazeneca Pharma India receives DCGI approval to import, market Selumetinib capsules
 ( Hot Pursuit - 27-Sep-21   09:37 )
  AstraZeneca Pharma tanks on reverse turnaround in Q3
 ( Hot Pursuit - 06-Feb-18   11:30 )
  Astrazeneca Pharma India standalone net profit declines 98.53% in the March 2016 quarter
 ( Results - Announcements 25-May-16   17:43 )
  Astrazeneca Pharma soars after receiving regulatory nod for importing Andexxa
 ( Hot Pursuit - 20-Jan-24   13:14 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 04-Aug-20   10:39 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top